2026-04-17T14:59:37Zhttps://recercat.cat/oai/request

oai:recercat.cat:20.500.12328/16012025-05-20T00:02:12Zcom_2072_67741col_2072_484352

00925njm 22002777a 4500 dc Silecchia, Valeria author Valerio, Enrico author Merazzi, Daniele author Iantorno, Lorenzo author Laguardia, Maria Chiara author Cutrone, Mario author Grimalt Santacana, Ramon author 2019 We here present a case of neonatal skin damage due to application of methylene blue (MB) on a newborn's skin. MB use should be completely eliminated in neonatal intensive care units and nurseries, because of three potentially dangerous adverse effects of this compound: (1) It may act as an irritant when applied topically on intact skin, leading to skin reddening up to deep full-thickness eschars; (2) Is possesses photosensitizing properties, and may produce skin reddening followed by blisters and peeling after UV phototherapy; (3) It is a proscribed substance in patients affected by glucose-6-phosphate dehydrogenase deficiency, a condition not easily detected in the very first days of life. Silecchia, Valeria; Valerio, Enrico; Merazzi, Daniele [et al.]. Why methylene blue should be blacklisted in neonatology. Journal of Respiratory Research, 2019. 5(1), p. 1-2. Disponible en: <http://www.ghrnet.org/index.php/jdr/article/view/2731/3037>. Fecha de acceso: 23 jun. 2020. DOI:10.17554/j.issn.2412-2424.2019.05.46-5 2412-2424 http://hdl.handle.net/20.500.12328/1601 http://dx.doi.org/10.17554/j.issn.2412-2424.2019.05.46-5 Neonatologia Dermatologia Pediatria intensiva Neonatología Dermatología Cuidados intensivos neonatales Neonatology Dermatology Intensive care, neonatal Why methylene blue should be blacklisted in neonatology